Coya Therapeutics (COYA) Institutional Ownership $6.03 -0.04 (-0.66%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Coya Therapeutics (NASDAQ:COYA)CurrentInstitutional OwnershipPercentage39.75%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$17.45MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$306.32K Get COYA Insider Trade Alerts Want to know when executives and insiders are buying or selling Coya Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data COYA Institutional Buying and Selling by Quarter Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Coya Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC142,309$918K0.0%+3.3%0.852% 10/24/2024 GHP Investment Advisors Inc.26,171$169K0.0%N/A0.179% 8/9/2024 Renaissance Technologies LLC16,700$101K0.0%N/A0.114% 8/1/2024 Gilbert & Cook Inc.10,000$61K0.0%N/A0.068% 5/10/2024 Vanguard Group Inc.847,490$8.41M0.0%+772.3%5.804% 2/15/2024Greenlight Capital Inc.1,274,026$9.44M0.5%+172.2%12.702% 2/12/2024 AIGH Capital Management LLC1,031,977$7.38M2.9%+92.6%10.289% 2/9/2024 Worth Venture Partners LLC92,667$687K0.4%-30.8%0.924% 11/15/2023 Worth Venture Partners LLC134,006$519K0.3%-8.5%1.336% 11/13/2023 AIGH Capital Management LLC535,794$2.06M1.0%-8.7%5.342% 11/7/2023 CM Management LLC100,000$384K0.4%+66.7%1.005% 8/14/2023 Mirador Capital Partners LP15,361$63K0.0%N/A0.154% 8/4/2023 CM Management LLC60,000$244K0.2%N/A0.603% 2/16/2023 AIGH Capital Management LLC560,000$2.65M0.9%N/A5.785% (Data available from 1/1/2016 forward) COYA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of COYA shares? During the previous two years, 10 institutional investors and hedge funds held shares of Coya Therapeutics. The most heavily invested institutionals were Greenlight Capital Inc. ($9.44M), Vanguard Group Inc. ($8.41M), AIGH Capital Management LLC ($7.38M), Geode Capital Management LLC ($918K), Worth Venture Partners LLC ($687K), CM Management LLC ($384K), and GHP Investment Advisors Inc. ($169K).Learn more on COYA's institutional investors. What percentage of Coya Therapeutics stock is owned by institutional investors? 39.75% of Coya Therapeutics stock is owned by institutional investors. Learn more on COYA's institutional investor holdings. Which institutional investors have been buying Coya Therapeutics stock? Of the 9 institutional investors that purchased Coya Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($1.06M), Greenlight Capital Inc. ($805.96K), Vanguard Group Inc. ($750.34K), CM Management LLC ($100K), GHP Investment Advisors Inc. ($26.17K), Renaissance Technologies LLC ($16.70K), and Mirador Capital Partners LP ($15.36K). How much institutional buying is happening at Coya Therapeutics? Institutional investors have bought a total of 2,785,197 shares in the last 24 months. This purchase volume represents approximately $20.57M in transactions. Which Coya Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Coya Therapeutics stock in the last 24 months: Worth Venture Partners LLC ($53.83K), and AIGH Capital Management LLC ($51.08K). How much institutional selling is happening at Coya Therapeutics? Institutional investors have sold a total of 104,904 shares in the last 24 months. This volume of shares sold represents approximately $550.41K in transactions. Related Companies Canopy Growth Institutional Ownership Larimar Therapeutics Institutional Ownership Akebia Therapeutics Institutional Ownership KalVista Pharmaceuticals Institutional Ownership Verve Therapeutics Institutional Ownership 4D Molecular Therapeutics Institutional Ownership Alector Institutional Ownership Valneva Institutional Ownership Amylyx Pharmaceuticals Institutional Ownership Ginkgo Bioworks Institutional Ownership This page (NASDAQ:COYA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
